lamivudine

FDA Drug Profile — lamivudine, LAMIVUDINE, EPIVIR

Drug Details

Generic Name
lamivudine
Brand Names
lamivudine, LAMIVUDINE, EPIVIR
Application Number
ANDA211306
Sponsor
Camber Pharmaceuticals, Inc.
NDC Codes
11
Dosage Forms
TABLET, FILM COATED, POWDER, SOLUTION
Routes
ORAL
Active Ingredients
LAMIVUDINE

Indications and Usage

1 INDICATIONS AND USAGE Abacavir and lamivudine tablets, a combination of abacavir and lamivudine, both nucleoside analogue HIV-1 reverse transcriptase inhibitors, is indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection. ( 1 ) Abacavir and lamivudine tablets, in combination with other antiretroviral agents, are indicated for the treatment of human immunodeficiency virus type 1 (HIV-1) infection.